Capstone Investment Advisors, LLC Eli Lilly & CO Put Options Transaction History

Capstone Investment Advisors, LLC

$29.5 Billion
Q2 2024

Put Options

25 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $27.1 Million - $34 Million	37,400 Added 35.28%	143,400 $130 Million
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $39.9 Million - $53.4 Million	-67,400 Reduced 38.87%	106,000 $82.5 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $27.5 Million - $32.4 Million	52,300 Added 43.19%	173,400 $101 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $10.6 Million - $14.6 Million	24,300 Added 25.1%	121,100 $65 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $12.6 Million - $16.9 Million	36,000 Added 59.21%	96,800 $45.4 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $21.9 Million - $25.7 Million	-70,500 Reduced 53.69%	60,800 $20.9 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $20 Million - $23.3 Million	62,100 Added 89.74%	131,300 $48 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $16.4 Million - $18.7 Million	-55,400 Reduced 44.46%	69,200 $22.4 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $67 Million - $78.7 Million	-240,500 Reduced 65.87%	124,600 $40.4 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $118 Million - $146 Million	-501,900 Reduced 57.89%	365,100 $105 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $8.18 Million - $10.2 Million	36,400 Added 4.38%	867,000 $239 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $19.9 Million - $24.5 Million	-90,000 Reduced 9.78%	830,600 $192 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $44.9 Million - $58.1 Million	248,700 Added 37.01%	920,600 $211 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $32.5 Million - $42 Million	197,600 Added 41.66%	671,900 $126 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $7.45 Million - $9.86 Million	57,100 Added 13.69%	474,300 $80.1 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $19 Million - $22 Million	129,900 Added 45.21%	417,200 $61.8 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $3.83 Million - $4.61 Million	28,100 Added 10.84%	287,300 $47.2 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $16.9 Million - $20.9 Million	-141,800 Reduced 35.36%	259,200 $36 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $10.4 Million - $12.8 Million	97,000 Added 31.91%	401,000 $52.7 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $3.12 Million - $3.39 Million	29,200 Added 10.63%	304,000 $34 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $12 Million - $14 Million	108,100 Added 64.85%	274,800 $30.4 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $1.85 Million - $2.17 Million	-16,600 Reduced 9.06%	166,700 $21.6 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $2.28 Million - $2.55 Million	21,500 Added 13.29%	183,300 $21.2 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $12.8 Million - $16 Million	148,800 Added 1144.62%	161,800 $17.4 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $984,100 - $1.13 Million	13,000 New	13,000 $1.11 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

Lilly Endowment Inc Indianapolis, IN

97.4M
Shares

$85.4 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.9M
Shares

$64.8 Billion
1.31% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$57.8 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$45.1 Billion
31.1% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$29.7 Billion
1.36% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account